For Clinical Research Sites

Unleash how your site discovers and wins clinical trials

All-in-one, AI-automated, site business development platform

Streamline your business development with AI-powered study intelligence, automated outreach, and comprehensive pipeline management.

Trusted by 350+ clinical research sites across the US

QURI — STUDY FEED

For YouAll StudiesBookmarks

Dr. Dhillon — OphthalmologyDr. John — CardiologySite-wide — Pulmonology+

Weekly scout reportsDelivered every Monday

▤Week of 7/26/2026

↗4 new study opportunities

◍3 CT.gov rescue signals

23 total studies

▤Week of 7/19/2026

↗3 new study opportunities

◍3 CT.gov rescue signals

29 total studies

▤Week of 7/12/2026

↗13 new study opportunities

◍3 CT.gov rescue signals

31 total studies

▤Week of 7/5/2026

↗4 new study opportunities

◍3 CT.gov rescue signals

27 total studies

▤Week of 6/28/2026

↗0 new study opportunities

◍2 CT.gov rescue signals

25 total studies

▤ Jul 9, 2026Phase II

Evaluate Efficacy and Safety of PA5108 Ocular Implants in Primary Open Angle Glaucoma

Peregrine OphthalmicsOpen-Angle GlaucomaUpcoming

Sponsor & CRO contacts (23)3 of 23 emails unlocked

✓JKJordan KleinFeasibility Leadj.klein@sponsor.comin

✓ARAna RodriguezStudy Start-Up Managera.rodriguez@sponsor.comin

MPMarcus PellClinical Ops Director•••••••••••••Unlock emailin

SOSimone OkaforSite Selection, CRO•••••••••••••Unlock emailin

DVDev VarmaSr. Clinical Scientist•••••••••••••Unlock emailin

Showing 1–5 of 23‹›2 selectedAdd to outreach

▤ Jul 7, 2026Phase III

A Study of an Intravitreal Gene Therapy in Geographic Atrophy

Calyx ResearchGeographic AtrophyUpcoming

▤ Jul 2, 2026Phase I/II

Dose-Ranging Study of a Sustained-Release Implant for Ocular Hypertension

Northvale BioOcular HypertensionUpcoming

Platform

The Secret Weapon to Securing More Trials

05 / CAPABILITIES

01↓

Smart Study Discovery

Never miss an opportunity with AI-powered study intelligence.

02↓

Find Sponsor Contacts

Discover sponsor and CRO decision-makers, with emails.

03↓

Automated Outreach

AI sends personalized emails and LinkedIn messages, with scheduled follow-ups, automatically.

04↓

Pipeline Management

Track, visualize, and manage the opportunities you’re pursuing.

05↓

AI Completes FQs

AI fills out feasibility questionnaires for you based on your site profile.

Study Intelligence & Sponsor / CRO Contacts

Catch Every Trial. Connect with Sponsors.

01Study Sourcing

AI scans and scrapes the web (ClinicalTrials.gov, press releases, news articles, sponsor websites, 10-K's, and more) and aggregates everything in one feed.

02Contact Sourcing

AI scrapes LinkedIn and trade show attendee lists for sponsor/CRO decision makers. Access their emails and go to their LinkedIn profiles.

03Personalized "For You" Feed

Enter your site's therapeutic areas, indications, or keywords (i.e. GLP-1) and AI will curate a tailored feed of relevant trials, complete with daily email alerts.

Study Pipeline Tracking

Stay Ahead & On Top of Your Opportunities.

01Visualize Your Pipeline

Track study leads, progress, and forecasts by PI, location, indication, or status in a dynamic dashboard.

02Set Tasks & Reminders

Set alerts for key milestones like sponsor follow-ups or IRB submissions.

03Multi-User Collaboration

Assign tasks and communicate across your team within the platform.

Pipeline — Q3 2026By PI ▾By Indication ▾

Identified12

Phase 3 COPD maintenance

Northvale Bio · Pulmonology

Added Aug 2RM

Resistant hypertension 2b

Meridian Tx · Cardiology

Added Aug 1JD

Contacted8

GLP-1 combination T2D

Aldera Pharma · Endocrine

Follow-up Aug 12JD

Nephrology Phase 2 start

Calyx Research

Reply receivedRM

CDA Executed6

Phase 3 asthma extension

Northvale Bio · Pulmonology

Signed Jul 30PR

Heart failure registry

Brightwater · Cardiology

Signed Jul 26JD

FQ Submitted5

Glaucoma implant Phase 2

Peregrine · Ophthalmology

Sent Jul 28PR

Geographic atrophy Phase 3

Calyx Research

Sent Jul 24RM

PSV Scheduled3

COPD biomarker sub-study

Meridian Tx · $412K

PSV Sep 9JD

Diabetes device trial

Aldera Pharma · $286K

PSV Sep 18RM

New opportunities / month+34%

Aug

Sep

Oct

Nov

Dec

Jan

Pipeline conversion

Identified48 · 100%

Contacted31 · 65%

CDA Executed19 · 40%

FQ Submitted12 · 25%

PSV Scheduled7 · 15%

Win rate & response

38%

Site selected
after FQ

23%

Sponsor reply
rate

Median days to CDA18

AI-Automated Email & LinkedIn Outbound

Engage with Sponsors. On Autopilot.

Growth+ plan

Not just email — automated LinkedIn connection requests and DMs, where sponsors are far more likely to reply.

Sequences run across both channels from your own accounts, so a missed inbox never ends the conversation.

Email onlyOne channel to miss

Email + LinkedIn DMMore ways to land a reply

01AI-Generated Messages

AI creates tailored emails and LinkedIn messages for review and editing, based on your site profile, study details, and why you're a perfect fit.

02Multi-Step Follow-Ups

Set up automated email and LinkedIn sequences (e.g. initial outreach, 7-day reminder) to re-engage unresponsive prospects.

03Add Contacts

Upload your own contacts or select contacts discovered in the platform. Add them to your created email sequence.

04Sent from Your Inbox

Integrates with your email inbox to send messages on your behalf, maintaining your personal touch.

Sequence template — Sponsor outreachActive

Sent

212

Opened

68%

Replied

23%

Meetings

Steps — click to preview

+ Add step

{ }

{{contact_role}} · {{sponsor}}

Template

EmailDay 0

Subject

Site capacity for your {{study_phase}} {{indication}} program

Hi {{first_name}} — I saw {{sponsor}}'s {{study_name}} post to {{source}} last week. {{site_name}} has run {{trials_in_indication}} {{indication}} trials since {{first_active_year}}, with a {{enrollment_rate}} enrollment rate and {{patient_database_size}} patients in our database. Would a 20-minute feasibility conversation be useful before your site selection closes?

Edit templateSends from your inbox

AI-Powered FQ Completion

Let AI Fill Out Feasibility Questionnaires For You

01Input Site Data

Upload previously completed FQs to populate your site profile with details like patient access, staff, and facilities — AI does the rest.

02Online Form Automation

Use our Google Chrome extension to auto-fill web-based FQs instantly on website pages with one click.

03Word Document Automation

Upload Word doc FQs, and AI generates tailored responses within a new downloadable file.

Sponsor feasibility questionnaire✕+

← → ⟳sponsor-portal.com/feasibility/fq-2418Q⋮

11.Based on our criteria, how many patients with NYHA Class II–III heart failure can your site recruit within 6 months?

Michigan Institute of Research can recruit 25–30 patients with NYHA Class II–III heart failure within 6 months, based on our cardiology database of 3,000 patients.AI filled

12.Describe your site's experience conducting Phase II or III cardiology trials in the past 3 years, including the number of trials and key indications.

Since 2022, Michigan Institute of Research has conducted 4 Phase II and 3 Phase III cardiology trials, enrolling 250 patients across heart failure (120), hypertension (80), and atrial fibrillation (50), meeting or exceeding targets in 90% of trials.AI filled

13.Does your site have an on-site echocardiography lab and certified cardiologists available for this trial?

AI FQFiller

AI successfully detected and extracted 78 questions, generated 65 answers, and filled out 65 fields.

Generate Answers and Fill Out Form

Site profileSynced

65 of 78 fields auto-filled · 13 need review

Pricing

Join the community of 350+ sites securing more trials today

Pay-as-you-go | Cancel anytime

Get Started

Schedule a demo or send us a message

Book meeting here

Schedule a personalized demo with our team to see how Quri.ai can transform your clinical trial pipeline.

Or contact us here